You already joined the company in 2001, and returned after an MBA in the USA in 2004. This was also the time the company really took…
In Conversation
You already joined the company in 2001, and returned after an MBA in the USA in 2004. This was also the time the company really took…
Prior to your current position you served in a number of marketing and managerial roles including at Bayer and Sanofi-Synthelabo. What drove you to move from…
Quintiles first established its operations in India in 1997, which was a very early stage in clinical research. What have been the main changes undergone by…
Right after you started heading the India operations roughly 15 years ago, you had to oversee one the biggest mergers in the industry at that time.…
Ferring is a specialty biopharmaceutical company that operates in four strategic therapeutic areas. Globally, many pharma companies have been diversifying their portfolio, and entering the OTC…
Shire’s International Marketing to being COO of start-up medical device company, Medicsight. What about Ferring and your current role attracted you to take this job and…
While we have seen many MNCs becoming increasingly interested in India, the story of Nycomed has been quite unique. Rather than starting off with marketing and…
Gedeon Richter's Erik Bogsch discusses the company's 100th anniversary, it's growing international footprint and the future of Hungarian pharma.
We understand that you have been with Novo Nordisk for quite a while already. In the past decade, you also did not sit still in terms…
Since establishing Gedeon Richter’s operations here 16 years ago, you’ve been involved in the full array of the pharmaceutical spectrum, from R&D, sourcing API, sales and…
Focus Reports first met with Materia Medica in 2006. At the time, the company was enjoying an extremely rapid pace of growth. Looking back over the…
